BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31

BALCHEM CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026

$170.42−0.31 (-0.18%)

Close on Oct 19, 2026

Market cap: $5.49B
P/E (TTM): 33.5
Dividend yield: 0.56%

BALCHEM CORP income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	1,037	954	922	942	799	704	644	644	595	553	552	541	337	310	292	255	219
Cost of Revenue	667	617	620	662	556	480	432	439	406	372	384	397	240	221	206	177	152
Gross Profit	371	336	302	280	243	224	211	204	189	181	168	144	97	90	86	78	67
Research & Development	19	17	15	12	14	10	11	12	9.31	7.33	5.99	4.81	3.62	3.42	2.89	3.19	3.30
Selling, General & Admin	–	–	–	–	–	–	–	–	–	–	2.90	2.90	–	–	–	–	–
General & Administrative	67	68	53	56	42	44	37	28	28	28	22	21	12	10	11	9.47	8.65
Operating Expenses	161	153	143	135	116	113	109	97	92	90	74	62	32	30	30	28	26
Operating Income	209	183	159	145	128	111	103	107	97	91	94	82	66	60	56	50	41
Interest Expense	–	–	–	–	–	–	–	–	7.54	7.27	6.59	5.15	0.02	0.01	0.08	0.09	0.21
Interest & Investment Income	–	–	–	–	–	–	–	–	0.01	0.01	0.01	0.06	0.28	0.01	0.18	0.29	0.11
Other Non-Operating Income	-10	-16	-22	-11	-2.27	-4.73	-6.08	-8.07	-8.42	-0.65	-6.89	-5.09	0.22	0.07	0.51	0.36	-0.06
Merger & Restructuring Charges	–	0.52	7.76	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	0	0.52	7.76	0.02	1.68	1.92	1.14	1.80	0	0	0.30	0.15	0	0	0.09	0.31	0
Gain (Loss) on Sale of Assets	–	–	–	-0.34	1.73	-0.15	3.13	3.24	-0.25	-0.32	–	–	–	–	–	–	–
Legal Settlements	–	–	–	–	–	–	0	0	-2.09	–	–	–	–	–	–	–	–
Pretax Income	199	166	137	134	125	106	96	99	88	83	87	77	66	60	57	50	41
Income Tax Expense	44	38	29	28	29	22	17	20	-1.58	27	27	24	21	20	18	17	14
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	90	56	60	53	45	40	39	33	27
Net Income	155	128	109	105	96	85	80	79	90	56	60	53	45	40	39	33	27
Net Income to Common	–	–	–	–	–	–	–	79	90	56	60	53	45	40	39	33	27
EPS (Basic)(per share)	4.80	3.97	3.38	3.29	2.98	2.63	2.48	2.45	2.83	1.78	1.92	1.74	1.51	1.38	1.36	1.19	0.98
EPS (Diluted)(per share)	4.75	3.93	3.35	3.25	2.94	2.60	2.45	2.42	2.79	1.75	1.89	1.69	1.45	1.32	1.28	1.12	0.93
Shares Outstanding (Basic, Weighted)(shares)	32	32	32	32	32	32	32	32	32	32	31	30	30	29	29	28	27
Shares Outstanding (Diluted, Weighted)(shares)	33	33	32	32	33	33	33	32	32	32	32	31	31	30	30	30	29
Dividend per Share(per share)	0.96	0.87	0.79	0.71	–	–	–	–	–	–	–	–	–	–	–	–	–
EBITDA	255	231	214	197	176	162	148	152	141	137	134	113	76	69	66	58	49
Net Interest Income	–	–	-23	-10	-2.46	-4.44	-5.96	-7.61	-7.53	-7.26	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 36.3%
Operating margin: 20.4%
Net margin: 15.1%
Return on equity, FY2025: 12.9%

Financial strength

Current ratio: 2.66
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 43.3%

Valuation

P/E ratio: 33.5
Price to sales: 5.05
Price to book: 4.21
Dividend yield: 0.56%